Table 2.

The frequency of CA19-9 elevation was similar between the 2 groups. On the other hand, elevated CA125 was more frequently observed in patients with cancer.

Clinical characteristics	Normal CA19-9 (N=134)	Elevated CA19-9 (N=105)	P-value
Mean diameter (cm)	6.95±3.97	8.53±3.84	0.002
Bilaterality			0.369
Unilateral	116 (57.4%)	86 (47.6%)
Bilateral	18 (48.6%)	19 (51.4%)
CA125			0.350
Normal	125 (57.1%)	94 (42.9%)
Elevated	9 (45.0%)	11 (55.0%)
Pathologic component
Fat			< 0.001
Negative	107 (68.2%)	50 (31.8%)
Positive	27 (32.9%)	55 (67.1%)
Calcification			0.237
Negative	103 (58.5%)	73 (41.5%)
Positive	31 (49.2%)	32 (50.8%)
Soft tissue			1.000
Negative	96 (56.1%)	75 (43.9%)
Positive	38 (55.9%)	30 (44.1%)
Solid portion			1.000
Negative	125 (56.1%)	98 (43.9%)
Positive	9 (56.3%)	7 (43.8%)
Septation			1.000
Negative	121 (56.0%)	95 (44.0%)
Positive	13 (56.5%)	10 (43.5%)